UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010507
Receipt No. R000012287
Scientific Title Phase II trial of Combination with Paclitaxel, Carboplatin and Cetuximab (PCE) as a first line treatment in patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Date of disclosure of the study information 2013/04/16
Last modified on 2018/10/03 17:07:22

No. Disposal Last modified on Item of update
1 Insert 2013/04/16 15:09:53
2 Update 2013/04/16 22:37:43 Key secondary outcomes
3 Update 2013/04/16 22:40:08 Key exclusion criteria
4 Update 2013/08/01 14:01:53 UMIN ID1
5 Update 2013/08/01 14:13:08 Recruitment status
6 Update 2013/10/16 16:24:05 Public title
Acronym
7 Update 2013/10/16 16:24:44 Primary outcomes
8 Update 2013/10/16 16:26:03 Key inclusion criteria
9 Update 2013/10/16 16:33:34 Date of protocol fixation
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
10 Update 2013/10/16 16:36:19 Email
11 Update 2014/04/16 11:02:21 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
12 Update 2014/10/17 11:53:19 Recruitment status
13 Update 2016/05/16 09:55:20 Last name of contact person
Last name of contact person
Name of person sending information
Name of person sending information
Name of primary sponsor
Organization
Organization
Organization
Category of Funding Organization
14 Update 2016/05/16 09:57:58 Last follow-up date
Date of closure to data entry
Date trial data considered complete
15 Update 2018/04/19 10:35:06 Control
16 Update 2018/10/03 17:07:05 Public title
Acronym
17 Update 2018/10/03 17:07:22 Recruitment status


Contact us.